Recombinant CD40-ligand Uses, Dosage, Side Effects and more
Recombinant CD40-ligand is under investigation in clinical trial NCT00053391 (Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma).
Trade Name | Recombinant CD40-ligand |
Generic | Recombinant CD40-ligand |
Recombinant CD40-ligand Other Names | CD40 ligand, Recombinant CD40-ligand |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |